Skip to content

Injection Site Reactions on GLP-1 Medications: What to Know

Injection site reactions are common with GLP-1 medications and include redness, swelling, itching, or pain at the injection location. These reactions are usually mild and temporary, resolving within a few days. Proper injection technique and site rotation can significantly minimize their occurrence and severity.

How Common Is It?

Reported rates of injection site reactions vary by medication:

Rates shown are adult incidences from the clinical-trial sections of each medication's FDA prescribing information, checked on 31 July 2026. Pediatric trial rates differ — Wegovy vomiting is 24% in adults and 36% in patients aged 12 and older. Where a label reports a symptom only through post-approval reports, FDA states its frequency cannot be reliably estimated, so we show that rather than a number. Where a label does not list the symptom at all, we say so — that means no label basis for a rate, not that the symptom is rare or impossible. A symptom reported during treatment is not by itself proof the medication caused it.

Ozempic
semaglutide
0.2% of adults
Wegovy
semaglutide
1.4% of adults
Mounjaro
tirzepatide
3.2% of adults
Zepbound
tirzepatide
6-8% of adults

Why Do GLP-1 Medications Cause Injection Site Reactions?

  • The subcutaneous injection process itself can cause localized trauma to tissue, triggering a mild inflammatory response
  • Some patients may have sensitivity to GLP-1 medications or to the inactive ingredients in the GLP-1 medications formulation
  • Injecting medication that is too cold can increase local irritation and discomfort
  • Reusing the same injection site repeatedly can lead to tissue hardening (lipodystrophy) and increased reactions

When Does It Happen?

Injection site reactions typically appear within hours of the injection and resolve within 2-5 days. They are often more noticeable when starting GLP-1 medications and tend to become less frequent as patients develop better injection technique and the body adjusts to the medication.

How to Manage Injection Site Reactions on GLP-1 Medications

1

Rotate injection sites systematically between the abdomen, thigh, and upper arm, using a different spot each week

2

Allow the medication pen to reach room temperature for 15-30 minutes before injecting

3

Apply an ice pack to the injection site for 2-3 minutes before injecting to numb the area

4

Clean the injection site with an alcohol swab and let it dry completely before injecting

5

Inject slowly and steadily, holding the pen in place for 10 seconds after injection as directed

6

Avoid injecting into areas that are bruised, tender, scarred, or have stretch marks

When to Contact Your Doctor

Seek medical attention if you experience any of the following:

  • The injection site develops signs of infection such as increasing redness, warmth, swelling, or pus
  • A hard lump or nodule forms at the injection site and does not resolve within a week
  • You develop a rash or hives that spread beyond the injection site, which may indicate an allergic reaction
  • You experience severe pain at the injection site that worsens over time rather than improving
  • The injection site area develops unusual discoloration or skin changes

Track Injection Site Reactions with JellyPal

Log your injection site reactions episodes, identify patterns, and share detailed reports with your doctor. JellyPal helps you understand how your medication affects you over time.

Frequently Asked Questions

JellyPal Mascot

Take control of your side effects.

Track your GLP-1 journey, log side effects, and share reports with your healthcare provider.

Download on the App Store
Get JellyPal: GLP-1 Shot Tracker on Google Play
Get JellyPal Free